Protalix BioTherapeutics
PLX
#8915
Rank
ยฃ0.10 B
Marketcap
ยฃ1.30
Share price
-1.14%
Change (1 day)
-2.05%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): ยฃ7.09 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are ยฃ61.94 Million. In 2024 the company made an earning of ยฃ3.91 Million a decrease over its 2023 earnings that were of ยฃ8.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ7.09 M81.35%
2024 ยฃ3.91 M-55.62%
2023 ยฃ8.82 M-199.05%
2022 -ยฃ8.91 Million-40.38%
2021 -ยฃ14.94 Million-732.31%
2020 ยฃ2.36 M-130.53%
2019 -ยฃ7.74 Million189.85%
2018 -ยฃ2.67 Million-95.29%
2017 -ยฃ56.7 Million308.12%
2016 -ยฃ13.9 Million-32.37%
2015 -ยฃ20.55 Million10.11%
2014 -ยฃ18.66 Million-7.59%
2013 -ยฃ20.19 Million
2011 -ยฃ23.38 Million-19.39%
2010 -ยฃ29.01 Million20.87%
2009 -ยฃ24 Million32.26%
2008 -ยฃ18.15 Million-5.46%
2007 -ยฃ19.19 Million
2004 -ยฃ0.13 Million12.35%
2003 -ยฃ0.12 Million-11.1%
2002 -ยฃ0.13 Million-57.03%
2001 -ยฃ0.29 Million1.03%
2000 -ยฃ0.29 Million-53.22%
1999 -ยฃ0.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
ยฃ3.73 M-45.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.43 B 6,251.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.89 B 128,978.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.32 B 19,198.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel